RxDoctor Payments Data

Blair Lonsberry

Optometrist · Portland, ORNPI 1982645370

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $47,908 of the $76,431 with a category attached, or 62.7%. 20 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 46.1% of the total. Reporting peaked in 2019 at $22,637 and has fallen 60.8% since, to $8,865 in 2025. Among optometrist clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,431in general payments, 2019–2025

Across 150 payments — averaging $509.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$35K
  • Apellis Pharmaceuticals, Inc.$14K
  • Maculogix, Inc.$14K
  • Dompe US, Inc.$6K
  • Tarsus Pharmaceuticals, Inc.$2K
  • Thea Pharma Inc.$1K
  • plus $4K from 14 others

What the payments were for

  • Consulting fees$14,67319%
  • Speaking & faculty fees$47,90863%
  • Travel & lodging$5,7838%
  • Food & beverage$8,06811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,431 in reported general payments places this provider in the 95th percentile of 684 optometrist providers in Oregon.

See all optometrist providers in Oregon

Other optometrist in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →